Donor-derived herpes simplex virus hepatitis in a kidney transplant recipient and review of the literature

Transpl Infect Dis. 2021 Jun;23(3):e13562. doi: 10.1111/tid.13562. Epub 2021 Feb 2.

Abstract

Donor-derived (DD) herpes simplex virus (HSV) hepatitis in solid organ transplant (SOT) recipients is extremely uncommon but carries a high mortality rate. The diagnosis is challenging due to the non-specific presentation and lack of clinical suspicion. We report a case of DDHSV hepatitis in a HSV2 pre-transplant seronegative kidney recipient who received the organ from a HSV2 seropositive donor. The case is highlighted by a few unusual features, namely severe thrombocytopenia and the development of cutaneous, oral and esophageal HSV lesions several weeks after symptom onset while recovering on appropriate treatment. A review of nine proven and probable DDHSV hepatitis cases (including eight previously published ones) showed that fever is a common presenting feature while gastrointestinal symptoms and cutaneous manifestations are uncommon. The symptoms almost always occurred within 2 weeks of transplant. Six out of the nine DDHSV hepatitis patients, including five patients who were on appropriate treatment, died within a month after transplant.

Keywords: donor derived transmitted disease; herpes simplex virus hepatitis; kidney transplantation.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Hepatitis, Viral, Human*
  • Herpes Simplex*
  • Humans
  • Kidney Transplantation*
  • Simplexvirus
  • Tissue Donors